PhotoCure ASA (LTS:0IMT) Cyclically Adjusted Revenue per Share: kr15.21 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0IMT PhotoCure ASA LTS:0IMT
70 GF Score
Price kr57.90
GF Value kr69.78
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is PhotoCure ASA Cyclically Adjusted Revenue per Share?

PhotoCure ASA LTS:0IMT -0.52% 70 Cyclically Adjusted Revenue per Share is kr15.21 as of Mar. 2026. GuruFocus rates LTS:0IMT with a GF Score™ of 70/100 and a GF Value™ of kr69.78 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PhotoCure ASA's adjusted revenue per share for the three months ended in Mar. 2026 was kr9.884. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr15.21 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PhotoCure ASA's average Cyclically Adjusted Revenue Growth Rate was 15.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PhotoCure ASA was 14.90% per year. The lowest was 8.40% per year. And the median was 12.45% per year.

As of today (2026-07-20), PhotoCure ASA's current stock price is kr57.90. PhotoCure ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr15.21. PhotoCure ASA's Cyclically Adjusted PS Ratio of today is 3.81.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PhotoCure ASA was 17.97. The lowest was 3.43. And the median was 5.71.


PhotoCure ASA  (LTS:0IMT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PhotoCure ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=57.90/15.21
=3.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PhotoCure ASA was 17.97. The lowest was 3.43. And the median was 5.71.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PhotoCure ASA Cyclically Adjusted Revenue per Share Related Terms


PhotoCure ASA Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for PhotoCure ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhotoCure ASA Cyclically Adjusted Revenue per Share Chart

PhotoCure ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.02 10.24 12.05 14.02 15.21

PhotoCure ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.06 14.51 14.80 15.21 15.21

LTS:0IMT vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Cyclically Adjusted PS Ratio falls into.


LTS:0IMT
70GF Score
PhotoCure ASA LTS:0IMT
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhotoCure ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PhotoCure ASA's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.884/141.0300*141.0300
=9.884

Current CPI (Mar. 2026) = 141.0300.

PhotoCure ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.645 103.800 2.235
201609 1.635 104.200 2.213
201612 1.741 104.400 2.352
201703 1.687 105.000 2.266
201706 1.843 105.800 2.457
201709 1.664 105.900 2.216
201712 1.811 106.100 2.407
201803 1.921 107.300 2.525
201806 2.127 108.500 2.765
201809 2.047 109.500 2.636
201812 2.268 109.800 2.913
201903 2.445 110.400 3.123
201906 2.466 110.600 3.144
201909 2.854 111.100 3.623
201912 5.307 111.300 6.725
202003 2.515 111.200 3.190
202006 2.273 112.100 2.860
202009 1.856 112.900 2.318
202012 3.666 112.900 4.579
202103 3.314 114.600 4.078
202106 3.408 115.300 4.169
202109 3.232 117.500 3.879
202112 3.628 118.900 4.303
202203 3.044 119.800 3.583
202206 3.705 122.600 4.262
202209 3.978 125.600 4.467
202212 3.838 125.900 4.299
202303 3.908 127.600 4.319
202306 5.356 130.400 5.793
202309 4.043 129.800 4.393
202312 4.974 131.900 5.318
202403 4.355 132.600 4.632
202406 5.308 133.800 5.595
202409 4.509 133.700 4.756
202412 6.894 134.800 7.213
202503 4.672 136.100 4.841
202506 5.019 137.800 5.137
202509 5.083 138.500 5.176
202512 5.155 139.100 5.227
202603 9.884 141.030 9.884

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr15.21 mean?
PhotoCure ASA (LTS:0IMT) has a Cyclically Adjusted Revenue per Share of kr15.21 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PhotoCure ASA and its competitors.
Is PhotoCure ASA's Cyclically Adjusted Revenue per Share too high?
PhotoCure ASA's current Cyclically Adjusted Revenue per Share is kr15.21. Overall, PhotoCure ASA has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhotoCure ASA's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
PhotoCure ASA's Cyclically Adjusted Revenue per Share of kr15.21 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PhotoCure ASA and its competitors. PhotoCure ASA's current Cyclically Adjusted Revenue per Share is kr15.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhotoCure ASA stock overvalued right now?
Based on GuruFocus' analysis, PhotoCure ASA (LTS:0IMT) is currently considered Modestly Undervalued. The stock's GF Value™ is kr69.78, compared to a current price of kr57.90 — trading 17% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr15.21. PhotoCure ASA's overall GF Score™ is 70/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For PhotoCure ASA (LTS:0IMT), the current Cyclically Adjusted Revenue per Share is kr15.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhotoCure ASA (LTS:0IMT) Overvalued in 2026?

Based on GuruFocus' analysis, PhotoCure ASA stock appears to be undervalued. The current stock price of kr57.90 is trading 17% below its estimated GF Value™ of kr69.78. GuruFocus considers PhotoCure ASA to be Modestly Undervalued.

Key valuation signals for LTS:0IMT:

  • Cyclically Adjusted Revenue per Share: kr15.21
  • GF Value™: kr69.78 vs. price of kr57.90 (17% below fair value)
  • GF Score™: 70/100 with 1 warning sign

No single metric tells the full story. See the LTS:0IMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhotoCure ASA Business Description

Address Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.
70GF Score

Get the complete analysis for LTS:0IMT

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr57.90
Price
kr69.78
GF Value